Sam Brusco, Associate Editor04.02.24
Baxter has gained U.S. Food and Drug Administration (FDA) 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ safety software. The clearance lets clinicians use a single, integrated system across patient care settings.
The Novum IQ infusion platform, according to the company, integrates user experience across its LVP and syringe infusion pumps (SYR) to reduce burden of non-critical tasks.
Novum IQ LVP and Novum IQ SYR infusion pumps share a common user interface designed to accomplish association between a patient, medication, and pump through a digital on-screen barcode. Dose IQ safety software features a web-based, customizable drug library and dose error reduction system. It also includes exclusive titration error prevention technology designed to provide additional safety measures.
The IQ Enterprise Connectivity Suite, a scalable all-in-one server, integration engine and software application platform, is designed to simplify infusion system connectivity for the Novum IQ infusion platform.
Dose IQ Safety Software and IQ Enterprise Connectivity Suite are both certified to the UL 2900 Series of Standards.
Heather Knight, executive VP and group president, Medical Products and Therapies at Baxter, said: “Our goal, always, is to bring increased efficiency, safety and opportunity for informed decision-making to our customers, clinicians and the patients they serve. The Novum IQ platform represents a meaningful shift in how connected and intelligent infusion therapy can impact the way clinicians provide care. Offering Novum IQ large volume and syringe infusion pumps unlocks the potential of advanced, intuitive technologies that customers seek to meet their needs.”
The Novum IQ infusion platform, according to the company, integrates user experience across its LVP and syringe infusion pumps (SYR) to reduce burden of non-critical tasks.
Novum IQ LVP and Novum IQ SYR infusion pumps share a common user interface designed to accomplish association between a patient, medication, and pump through a digital on-screen barcode. Dose IQ safety software features a web-based, customizable drug library and dose error reduction system. It also includes exclusive titration error prevention technology designed to provide additional safety measures.
The IQ Enterprise Connectivity Suite, a scalable all-in-one server, integration engine and software application platform, is designed to simplify infusion system connectivity for the Novum IQ infusion platform.
Dose IQ Safety Software and IQ Enterprise Connectivity Suite are both certified to the UL 2900 Series of Standards.
Heather Knight, executive VP and group president, Medical Products and Therapies at Baxter, said: “Our goal, always, is to bring increased efficiency, safety and opportunity for informed decision-making to our customers, clinicians and the patients they serve. The Novum IQ platform represents a meaningful shift in how connected and intelligent infusion therapy can impact the way clinicians provide care. Offering Novum IQ large volume and syringe infusion pumps unlocks the potential of advanced, intuitive technologies that customers seek to meet their needs.”